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ABSTRACT
Background. The application of a uniform definition for acute kidney injury (AKI) is vital to advance understanding and
management of AKI. International Classification of Diseases (Tenth Revision) (ICD-10) coding is frequently used to define
AKI, but its accuracy is unclear. The aim of this study was to determine whether ICD-10 coding is a reliable method of
monitoring rates and outcomes of AKI in inpatients compared with biochemically defined AKI, and whether electronic
alerts (e-alerts) for AKI affect ICD-10 AKI coding.
Methods. An observational cohort study of all 505 662 adult admissions to acute hospitals in two Scottish Health Boards
[National Health Service (NHS) Tayside and NHS Fife] from January 2013 to April 2017 was performed. AKI e-alerts were
implemented in NHS Tayside in April 2015. Sensitivity, specificity, positive and negative predictive values of ICD-10 coding
for AKI compared with biochemically defined AKI using the Kidney Disease: Improving Global Outcomes definition and
relative risk of 30-day mortality in people with ICD-10 and biochemically defined AKI before and after AKI e-alert
implementation were performed.
Results. Sensitivity of ICD-10 coding for identifying biochemically defined AKI was very poor in both health boards for all
AKI (Tayside 25.7% and Fife 35.8%) and for Stages 2 and 3 AKI (Tayside 43.8% and Fife 53.8%). Positive predictive value was
poor both for all AKI (Tayside 76.1% and Fife 45.5%) and for Stages 2 and 3 AKI (Tayside 45.5% and Fife 36.8%). Measured
mortality fell following implementation of AKI e-alerts in the ICD-10-coded population but not in the biochemically defined
AKI population, reflecting an increase in the proportion of Stage 1 AKI in ICD-10-coded AKI. There was no evidence that the
introduction of AKI e-alerts in Tayside improved ICD-10 coding of AKI.
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Conclusion. ICD-10 coding should not be used for monitoring of rates and outcomes of AKI for either research or
improvement programmes.
Keywords: acute kidney injury, electronic alerts, epidemiology, ICD-10 coding
INTRODUCTION
Acute kidney injury (AKI) is associated with adverse patient out-
comes including increased length of hospital stay, mortality
and future development of chronic kidney disease [1–6].
However, there has previously been no universally accepted
definition of AKI and so establishing its true incidence has been
difficult [7–9]. The Kidney Disease: Improving Global Outcomes
(KDIGO) definition for AKI was developed in 2012 [10]. This has
been universally adopted and has led to a greater understand-
ing of the epidemiology and adverse outcomes associated with
AKI. There is a worldwide recognition of the need to improve
AKI care, with initiatives such as the global World Kidney Day
providing a platform to increase the recognition and awareness
of AKI [11] and with many countries launching national im-
provement programmes, including the National Health Service
(NHS) England ‘Think Kidneys’ campaign [12] and the Scottish
Patient Safety Programme AKI national collaborative [13].
Electronic alerts (e-alerts) for AKI, which are based on the
KDIGO definition, have been implemented in many hospitals
worldwide to facilitate earlier recognition.
Despite this, much research and many improvement pro-
grammes still use hospital International Classification of
Diseases (Tenth Revision) (ICD-10) discharge coding to identify
AKI [14–17]. ICD-10, first published in 1994 [18], does not account
for current AKI definitions, with the code N17 (acute renal fail-
ure) commonly being used despite not distinguishing between
different AKI stages or including a biochemical definition [19].
The aim of this study was to determine whether ICD-10 cod-
ing is a reliable method of identifying cases of AKI and measur-
ing AKI-associated mortality compared with AKI defined
biochemically using the KDIGO definition and whether ICD-10
coding rates changed with the introduction of AKI e-alerts in
NHS Tayside in 2015.
MATERIALS AND METHODS
Study design
The study design was an observational cohort study. We in-
cluded all patients aged 18 years and not receiving renal re-
placement therapy (RRT) who were admitted to an NHS acute
hospital in Tayside or Fife health boards between 1 January 2013
and 30 April 2017. Apart from some elective surgery, all inpa-
tient healthcare and biochemistry laboratory testing in the two
health boards studied is provided by the NHS. There are approx-
imately 40 000 medical admissions, 16 000 surgical admissions
and 2800 intensive care admissions per year to NHS Tayside.
NHS Fife has 34 000 medical admissions, 13 000 surgical admis-
sions and 2400 intensive care admissions per year.
Data sources
Data were provided by the Health Informatics Centre (HIC) at
the University of Dundee [20], linking data from the Community
Health Index (CHI) patient register; Scottish Morbidity Record of
hospital admissions excluding psychiatric admissions (SMR01);
NHS biochemistry results; General Register Office (GRO)
national death registration; and the Scottish Renal Registry [21].
Data on ICD-10 discharge coding were obtained from SMR01,
data on biochemically defined AKI were obtained from the labo-
ratory results database and data on mortality were obtained
from the GRO death database and CHI database. The Scottish
Renal Registry [21] was used to identify those who were receiv-
ing RRT (chronic dialysis or transplant) prior to admission.
Definitions
ICD-10-coded AKI was defined as a patient having N17 (acute re-
nal failure) recorded as a discharge diagnosis. Biochemical AKI
was defined using the NHS England algorithm based on the
KDIGO definition (Supplementary data, Appendix) [10, 12].
Baseline was taken as the median creatinine level in the period
between 8 and 365 days prior to the index creatinine measure-
ment or, if not available, the lowest level in the period 0–7 days
prior to the index measurement or the lowest level between 0
and 2 days prior to the index measurement. In the absence of
any baseline measure, an increase of >26 mmol/L in creatinine
level in a 48-h window was also labelled as AKI Stage 1.
AKI Stage 1 was defined as an increase in serum creatinine
of 26.4 mmol/L or an increase of 1.5–1.9 times baseline. AKI
Stage 2 was defined as an increase in serum creatinine to 2–2.9
times the baseline value. AKI Stage 3 was defined as an increase
in serum creatinine to 3 times the baseline value or serum cre-
atinine of 354 mmol/L or initiation of RRT. Where there were
multiple AKI episodes identified in biochemistry data, the high-
est stage of AKI during the admission was used.
Statistical analysis
All analyses were performed using Stata (Version 14) and IBM
SPSS (Version 22) software.
Validity and predictive value of ICD-10 coding for AKI. The sen-
sitivity, specificity, and positive and negative predictive values
of ICD-10 code N17 compared with biochemically defined AKI
were calculated with 95% confidence intervals (CIs). These val-
ues were calculated for the overall study period as well as for
before and after the introduction of the AKI e-alerts. We sepa-
rately compared ICD-10 coding with all biochemically defined
AKI and for AKI Stages 2 and 3 combined. To examine whether
ascertainment of less severe AKI using ICD-10 coding changed
overtime, the proportion of total AKI consisting of AKI Stage 1
was also reported for pre- and post-intervention periods for
ICD-10-coded cases that were also biochemically defined.
Mortality rates of coded versus biochemically defined AKI.
Thirty-day mortality was calculated for people with ICD-10-
coded AKI and biochemically defined AKI, defined as the num-
ber of deaths as a proportion of the number of AKI cases from
date of admission. Data were tested for normality using the
Shapiro–Wilk test [22]. The relative risk (RR) of death before and
after the introduction of the AKI e-alerts was calculated for
coded and biochemically defined AKI, with 95% CIs reported for
the results.
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Interrupted time series and segmented regression analysis. An
interrupted time series with segmented regression analysis [23]
was used to assess whether there were changes in the propor-
tion of admissions coded as having AKI associated with the in-
troduction of the e-alerts in NHS Tayside (April 2015) compared
with changes in NHS Fife at the same time (where e-alerts were
not introduced). Monthly rates of ICD-10-coded AKI were de-
fined as the number of patients coded as having AKI as a pro-
portion of all patients aged 18 years admitted to hospital each
month. Rates were plotted over time, and the functional form of
the relationship before and after the intervention was assessed
for linearity. The Kolmogorov–Smirnov test [24] and the
Shapiro–Wilk test [22] were used to check data were normally
distributed. Segmented regression analysis was used to exam-
ine changes associated with the introduction of e-alerts. The
Durbin–Watson statistic was used to explore first-order auto-
correlation [25], with adjustment for autocorrelation using lag
terms as required. The changes in level and trend were reported
with 95% CIs, and the effect size of the intervention at
24 months was converted into a relative percentage difference
between the predicted and the actual ICD-10-coded AKI rates.
Ethical considerations
Anonymized record linkage was performed according to HIC
Standard Operating Procedures (SOPs). The Tayside Research
Ethics Committee does not require submission of individual
studies that follow SOPs. The research protocol was reviewed
and approved by the University of Dundee, School of Medicine
Research Ethics Committee.
RESULTS
There were 240 227 eligible hospital admissions in NHS Tayside
and 265 435 eligible hospital admissions in NHS Fife between 1
January 2013 and 30 April 2017 (Figure 1). The demographic
characteristics of NHS Tayside and NHS Fife cohorts were simi-
lar for age, sex and deprivation status. The mean (standard de-
viation [SD]) age for those included for analysis was 63 (19) in
Tayside and 61 (18) in Fife. Tayside’s cohort was 53.9% female,
comparable to 54.9% female in Fife. In Tayside, 34% of the co-
hort resided in the two most deprived Scottish Index of Multiple
Deprivation (SIMD5) quintiles, compared with 43% in Fife.
Over the course of the study, there were 20 967 episodes of
biochemically defined AKI (13 638 AKI Stage 1 and 7239 Stages 2
and 3) and 7068 cases of N17 ICD-10-coded AKI in NHS Tayside.
In NHS Fife, there were 17 454 episodes of biochemically defined
AKI (11 029 AKI Stage 1 and 6425 Stages 2 and 3) and 9386 cases
of ICD-10-coded AKI.
There were 413 cases of coded AKI in Tayside that fell into a
set of ICD-10 codes used by Mansfield et al. [14] to define AKI,
and 633 cases in Fife (Supplementary data, Table S1). However,
our analysis focused on the N17 code only.
Missing data
There were 7983 patients in Tayside and 9504 patients in Fife
for whom demographic data from SIMD5 could not be obtained.
Assessing the predictive value of ICD-10 coding for AKI
In both health boards over the whole period studied, sensitivity
of ICD-10 coding compared with gold standard biochemically
defined AKI was poor for all stages of AKI (25.7% in Tayside and
35.8% in Fife) and for Stages 2 and 3 AKI (43.8% in Tayside and
53.8% in Fife). Positive predictive values were moderate or poor
for all AKI (76.1% in Tayside and 45.5% in Fife) and for Stage 2
and 3 AKI (45.5% in Tayside and 36.8% in Fife). Specificity and
negative predictive value over the whole period studied were
both consistently high (97.7% and 93.3%, respectively)
(Table 1).
In Tayside, there was an increased proportion of coded AKI
consisting of AKI Stage 1 (N¼ 5378; 76.1% of total ICD-10-coded
AKI) following the introduction of the AKI e-alerts [pre-interven-
tion: 38.1%; post-intervention: 42.4%; þ4.3% (1.6–6.9)] but a non-
significant reduction in those with biochemically defined AKI
[pre-intervention: 65.6%; post-intervention: 64.4%; 1.3% (2.6
to 0.04)]. In NHS Fife, where e-alerts were not introduced, there
was a similar increase in the proportion of coded AKI consisting
of AKI Stage 1 (N¼ 6242; 66.5% of total ICD-10-coded AKI) for the
FIGURE 1: Flow chart showing the derivation of cohorts from the Tayside and Fife regions.
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same time frame [pre-intervention: 41.3%; post-intervention:
48.3%; þ6.9% (4.5–9.4)], though there was a small increase in
those with biochemically defined AKI [pre-intervention: 62.1%;
post-intervention: 64.6%; þ2.5% (1.0–3.9)].
In Tayside, with N17-coded AKI, sensitivity was 23.7% (22.9–
24.5%) before the introduction of the alerts and 27.9% (27.1–
28.8%) after the introduction of the alerts. For more severe AKI,
pre-intervention sensitivity was 42.6% (41.1–44.2%) and post-in-
tervention was 45.2% (43.5–46.9%) (Table 2). In NHS Fife, sensi-
tivity of N17 was 33.2% (32.3–34.1%) before the introduction of
the alerts in Tayside and 39.1% (38.0%–40.2%) after the introduc-
tion of the alerts. For more severe AKI stages, pre-intervention
sensitivity was 51.4% (49.8–53.0%) and post-intervention sensi-
tivity was 57.1% (55.2–59.0%) (Table 2).
Mortality rates after admission with ICD-10-coded
versus biochemically defined AKI
Thirty-day mortality was high irrespective of how AKI was iden-
tified (Table 3). Thirty-day mortality after date of admission for
ICD-10-coded AKI was 19.8 and 16.0% before and after e-alert
introduction in NHS Tayside and 18.7 and 16.8% in the same
periods in NHS Fife. For those with biochemically defined AKI,
30-day mortality after date of admission was 18.2 and 18.1% in
NHS Tayside before and after e-alert introduction and was 18.5
and 19.6% in the same periods in NHS Fife. In both health
boards, 30-day mortality rates were lower in ICD-10-coded AKI
in the period after NHS Tayside introduced e-alerts [NHS
Tayside RR 0.81 (0.73–0.90) and NHS Fife RR 0.90 (0.82–0.98)].
However, there were no differences in 30-day mortality rates in
people with biochemically defined AKI [NHS Tayside RR 1.00
(0.94–1.06) and NHS Fife RR 1.06 (0.99–1.12)].
Interrupted time series and segmented regression
analysis of change in ICD-10-coded AKI after the
introduction of e-alerts
The pre- and post-intervention rates were plotted over time, as
shown in Figure 2. Over the course of the study, 31/1000 of NHS
Tayside inpatients were coded with ICD-10 code N17 compared
with 35/1000 in NHS Fife. Results of segmented regression
analysis (Table 4) for NHS Tayside showed that there was no
Table 1. Sensitivity, specificity, and positive and negative predictive values of ICD-10 code N17 for biochemically defined AKI
Health board Sensitivity (95% CI) Specificity (95% CI) Positive predictive value (95% CI) Negative predictive value (95% CI)
Over study period all stages
Tayside 25.7 (25.0–26.3) 99.2 (99.2–99.3) 76.1 (75.1–77.0) 93.3 (93.3–93.4)
Fife 35.8 (35.1–36.5) 98.7 (98.7–98.8) 66.5 (65.6–67.4) 95.6 (95.6–95.7)
Over study period Stages 2 and 3
Tayside 43.8 (42.7–45.0) 98.3 (98.3–98.4) 45.5 (44.5–46.5) 98.2 (98.2–98.3)
Fife 53.8 (52.6–55.0) 97.7 (97.7–97.8) 36.8 (36.0–37.6) 98.8 (98.8–98.9)
Table 2. Sensitivity [% (95% CI)] before and after Tayside e-alert introduction of ICD-10 code N17 for biochemically defined AKI
Health board Sensitivity before Tayside e-alerts Sensitivity after Tayside e-alerts Difference in sensitivity
Tayside
All stages 23.7 (22.9–24.5) 27.9 (27.1–28.8) 4.27 (4.27–4.28)
Stages 2 and 3 42.6 (41.1–44.2) 45.2 (43.5–46.9) 2.57 (2.56–2.58)
Fifea
All stages 33.2 (32.3–34.1) 39.1 (38.0–40.2) 5.87 (5.87–5.88)
Stages 2 and 3 51.4 (49.8–53.0) 57.1 (55.2–59.0) 5.69 (5.68–5.71)
aThere was no intervention in NHS Fife, with AKI e-alerts only implemented in Tayside during the period of analysis. Pre- and post-interventions are for comparison
with observed differences in NHS Tayside.
Table 3. Mortality (%) over study period and relative risk (95% CI) in post- versus pre-intervention periodsa
Tayside Fife
Pre-intervention Post-intervention Pre-intervention Post-intervention
N17 ICD-10-coded AKI: 30-day mortality
Total 3535 3533 4644 4742
30-Day mortality (N) 700 567 870 798
% Mortality 19.8 16.0 18.7 16.8
Relative risk (95% CI) 0.81 (0.73 to 0.90) 0.90 (0.82 to 0.98)
Biochemical AKI: 30-day mortality
Total 11 243 9724 9829 7625
30-Day mortality (N) 2046 1763 1823 1495
% Mortality 18.2 18.1 18.5 19.6
Relative risk (95% CI) 1.00 (0.94–1.06) 1.06 (0.99–1.12)
aThis analysis included all cases of ICD-10-coded AKI.
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significant change in level at the time of the introduction of the
e-alerts and the change in trend indicated that coded AKI rates
had in fact fallen since the introduction of the alerts compared
with prior trends [b1: 0.36 (0.15–0.57), b2: 0.28 (4.41 to 3.84)
and b3: 0.39 (0.69 to 0.08)]. The absolute change at 24-
months post-intervention was 9.5 (17.2 to 1.8) and the
relative change was 27.0% (42.9% to 11.0%), with the overall
effect being a flattening of the previous rising trend. Results for
NHS Fife demonstrated that there was no change in either level
or trend over the course of the study [b1: 0.40 (0.10 to 0.69), b2:
2.61 (7.82 to 2.60) and b3: 0.29 (0.64 to 0.05)].
DISCUSSION
This large observational study of more than 500 000 inpatients
showed that using ICD-10 codes to monitor rates and outcomes
from AKI is unreliable and potentially misleading, with unac-
ceptably poor sensitivity and moderate positive predictive value
compared with biochemically defined AKI. This was true for all
AKI and the subset of more severe Stages 2–3 AKI. We antici-
pated that the introduction of the AKI e-alerts in NHS Tayside
in April 2015 would lead to an increase in the rates of ICD-10-
coded AKI because of increased recognition and awareness by
clinicians. However, this was not the case, with similar patterns
of coding over time observed in both NHS Tayside (where
e-alerts were introduced) and NHS Fife (where they were not).
Incidence is therefore seriously underestimated using ICD-10-
defined AKI, and mortality additionally falsely appears to
FIGURE 2: Rates of biochemically defined (red) and ICD-10-coded AKI (blue) before and after the implementation in NHS Tayside of AKI e-alerts (vertical line, e-alerts
are not implemented in NHS Fife but changes at the same time point are modelled).
Table 4. Segmented regression analysis of interrupted time-series
data to determine whether coded rates of AKI are changing overtime
Health board Coefficient (95% CI) P-value
Tayside
Baseline trend b1 0.36 (0.15 to 0.57) 0.00
Level change b2 0.28 (4.41 to 3.84) 0.89
Trend change b3 0.39 (0.69 to 0.08) 0.02
Fife
Baseline trend b1 0.40 (0.10 to 0.69) 0.01
Level change b2 2.61 (7.82 to 2.60) 0.32
Trend change b3 0.29 (0.64 to 0.05) 0.09
Level change: immediate change in AKI rates due to intervention.
Trend change: change in slope gradient pre- and post-interventions.
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reduce over time because of increased ICD-10 coding of less se-
vere biochemically defined cases.
The consistently low sensitivity of ICD-10 code N17 for bio-
chemically defined AKI has significant implications for moni-
toring the impact of the growing number of programmes to
improve AKI care. Using ICD-10 code N17 to monitor outcomes
from AKI improvement programmes is likely to significantly un-
derestimate true AKI rates, and as the sensitivity varies by AKI
stage and over time, evaluation of changes in incidence and se-
verity are at high risk of bias. The results also suggest that there
is unlikely to be a simple way to improve the accuracy of ICD-10
coding for AKI given that the coding rates were largely unaf-
fected by the e-alerts, a system designed to improve recognition
and awareness of AKI.
The findings also show that observed reductions in mortality
are at high risk of ascertainment bias. The mortality rate of ICD-
10-coded AKI appears to be reducing over time, but this is likely
due to a changing denominator where more cases of Stage 1
AKI are coded over time. This increasing proportion of less se-
vere AKI cases being coded makes it difficult to assess the true
impact of improvement efforts on mortality rates using ICD-10-
coded AKI.
Several studies have assessed the validity of administrative
database coding for AKI [26–32]. Vlasschaert et al.’s [33] review
in 2011 drew on a range of studies that mostly used ICD-9 codes
and concluded that sensitivity to detect AKI was poor overall
(median 29%) and positive predictive values were variable, com-
parable to our findings. Hwang et al. [31] assessed the validity of
ICD-10 code N17 specifically, and this study was published after
the Vlasschaert review. They found sensitivity of 37.4% for peo-
ple presenting to the emergency department and 61.6% for
those admitted to hospital [31]. However, Hwang’s study only
included those aged 66 years and, unlike our study, the refer-
ence standard used was not based upon the most recent KDIGO
AKI definition [10], which includes less severe AKI cases. This
would be consistent with the higher sensitivity (43.8% in
Tayside and 53.8% in Fife) for Stages 2 and 3 AKI observed in
this study. None of the studies examining sensitivity and other
performance measures examined change over time in the con-
text of AKI e-alert introduction. A recently published study by
Campbell et al. [34], which looked to determine the extent of
under-reporting of AKI using the ICD-10-AM (Australian
Modification) in four Australian hospitals, found there to be a
poor sensitivity of the ICD-10-AM codes for picking up AKI, im-
proving for more severe AKI cases [34], which supports the find-
ings of our study. Siew and Davenport. [35] reviewed the rising
trends of AKI incidence and explored possible causes, discus-
sing that the rising trends in coded AKI reported in some studies
may be explained by an increased awareness of AKI and
changes in coding practices, in particular when discharge codes
can be used as part of healthcare reimbursement [35]. This is an
interesting comparison to make with our study, where signifi-
cant increases in AKI coding rates were not noted over time, in
a region where ICD-10 coding is not used for healthcare reim-
bursement. Waikar et al. had previously alluded to the possibil-
ity that a decline in mortality could in part be explained by
increased coding of less severe AKI [26] and Sawhney and Fraser
[36] also discussed the easier recognition of milder AKI as an ex-
planation for falling mortality in some studies [36], but the limi-
tations of using coding data to study AKI mortality has not been
fully addressed in previous studies. ICD-10 will be replaced by
ICD-11, which will differentiate between different AKI stages
and include a biochemical definition [37], but whether this will
lead to improved coding of AKI remains unclear. While utilizing
biochemistry data to measure AKI for research and improve-
ment would be ideal, access to such datasets can be complex
and challenging.
Strengths of this study are its large size, examination in two
health boards serving distinct populations where coding practi-
ces could plausibly vary and the use of a robust quasi-
experimental design to examine the impact of AKI e-alerts on
coding practices [23, 38]. When examining the performance of
ICD-10 coding to identify AKI, we defined AKI using the KDIGO
definition [10].
However, there were some weaknesses. While being able to
compare NHS Tayside and NHS Fife is an important strength of
this study, there are also factors that differ between the regions
that were difficult to account for within the analysis. Within
Tayside, over the last few years, there have been several initia-
tives introduced to improve AKI recognition and care. In addi-
tion to the introduction of the e-alerts, the first Scottish health
board to do so, AKI management guidelines have been redevel-
oped along with an educational video aimed at junior doctors
and nursing staff [39]. An educational lanyard card was devel-
oped to provide an easily accessible reminder about risk factors,
essential tests and management steps for AKI, and both the
video and the lanyard card were used at junior doctor induction
and as part of AKI Awareness Week [39]. These efforts to in-
crease awareness and management of AKI in Tayside were not
paralleled with the Fife care system, and this may have had an
impact on the results.
Throughout Scotland, ICD-10 coding is based upon discharge
diagnoses stated within the discharge letters, often by junior
members of the team. An administrative coder is then responsi-
ble for using the discharge diagnoses provided to select the ad-
ministrative code that best aligns itself with the diagnoses
provided. This process is therefore limited by the accuracy of
the discharge letter provided and the experience of the coding
staff. Additionally, there are considerable differences in the fi-
nancial incentives to ensure accurate ICD-10 coding among
Scotland, England and other regions such as the USA and
Canada. The introduction of the Payment by Results scheme for
NHS England, which is based on ICD-10 coding, is suggested to
have led to an improvement in coding accuracy in a systemic
review [40]. Similarly, regions like the USA and Canada use ICD-
10 coding for reimbursement and allocation of resources, and
therefore it is plausible that there is an increased drive in these
regions to ensure accurate coding practices are upheld.
However, the same study also notes that there were no consid-
erable differences between Scotland and England [40], despite
the Payment by Results system not being used in Scotland.
Additionally, different regions can modify the World Health
Organisation ICD-10 codes for use in their own region, such as
ICD-10-CA (Canada) [41], ICD-10-CM (Clinical Modification, USA)
[42] and ICD-10 Fifth Edition (UK) [43]. It is difficult to say what
impact these variabilities may have on the generalizability of
the results obtained in this study.
CONCLUSIONS
There are two main implications of this study. First, based on
these findings and previous research, ICD-10 coding is not suffi-
ciently robust to use to identify AKI for either research or im-
provement programmes.
Secondly, AKI e-alerts did not have any obvious impact on
AKI coding. Although the primary purpose of e-alerts is to im-
prove AKI detection and management, this was unexpected.
However, it is consistent with the evidence that AKI e-alerts
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have limited effect on patient outcomes [44]. There is a need for
more research evaluating the impact of e-alerts and other inter-
ventions in this population.
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